Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The JRS guideline for the management of chronic obstructive pulmonary disease 7th edition 2026.

Respiratory investigation·2026
Same author

A Case of Late Onset Type1 Narcolepsy Complicated by Sleep Apnea Syndrome in which Cataplexy Improved with CPAP Treatment.

Internal medicine (Tokyo, Japan)·2026
Same author

Three Mycobacterium avium genotypes classified by 1.4-Mb genomic inversion and single-nucleotide variations are tightly linked to disease progression.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Genetic susceptibility, terminal bronchiole pathology, and inflammation: An integrated mechanisms of the pathogenic process in chronic obstructive pulmonary disease.

Respiratory investigation·2026
Same author

A prospective, multicenter cohort study to identify unmet medical needs in Japanese patients with chronic obstructive pulmonary disease: The J-UNMET-COPD study protocol.

Respiratory investigation·2026
Same author

Novel Therapeutics for Chronic Obstructive Pulmonary Disease: From Empirical Bronchodilation to Precision Medicine.

Respirology (Carlton, Vic.)·2026

Related Experiment Video

Updated: Mar 3, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

11.2K

Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease.

Katsuhiro Onodera1, Hisatoshi Sugiura1, Mitsuhiro Yamada1

  • 1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Thorax
|April 30, 2017
PubMed
Summary

Levels of Growth Differentiation Factor 11 (GDF11) are decreased in patients with Chronic Obstructive Pulmonary Disease (COPD). Lower GDF11 is linked to cellular senescence and may play a role in COPD pathogenesis.

Keywords:
COPD PathologyOxidative Stress

More Related Videos

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.6K
Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

22.2K

Related Experiment Videos

Last Updated: Mar 3, 2026

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

11.2K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.6K
Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

22.2K

Area of Science:

  • Pulmonary Medicine
  • Cellular Biology
  • Molecular Biology

Background:

  • Cellular senescence is implicated in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD).
  • Growth Differentiation Factor 11 (GDF11), a TGF-β superfamily member, has shown potential rejuvenating effects.
  • Investigating GDF11 in COPD is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To quantify GDF11 levels in plasma and lung tissue of COPD patients.
  • To explore the relationship between GDF11 and cellular senescence in COPD.
  • To elucidate the functional role of GDF11 in COPD pathogenesis.

Main Methods:

  • Western blotting for plasma GDF11 quantification in two cohorts.
  • Immunohistochemistry and qPCR for lung GDF11 expression analysis.
  • In vitro and in vivo studies on GDF11's effects on cellular senescence induced by cigarette smoke extract (CSE) and elastase.

Main Results:

  • COPD patients exhibited significantly lower plasma GDF11 levels compared to controls.
  • Plasma GDF11 levels positively correlated with pulmonary function.
  • GDF11 treatment inhibited CSE-induced senescence and inflammation in vitro and attenuated emphysema in vivo.

Conclusions:

  • Decreased GDF11 levels are associated with cellular senescence in COPD.
  • GDF11 may serve as a potential therapeutic target for COPD.
  • Further research into GDF11's role in COPD is warranted.